Brown S R, Anderson J P, Hughes D C. "一种拉替拉韦甲氧基乙酯-腙的合成方法" [P]. US Patent, US 11028143 B2, 2017-06-13.
发明人郑宇鹏,李文辉,杨光. "Method for the Synthesis of Raltegravir MethoxyEthylEster-Hydrazonic" [P]. 中国发明专利, 专利号 CN 108596457 A, 授权公告日 2015-11-28.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 拉替拉韦甲氧基乙酯-腙 in Pharmaceutical Formulations". Sci. Total Environ., 2021, 1731, (5), 8360-8380.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 拉替拉韦甲氧基乙酯-腙 as an Impurity". Talanta, 2017, 262, 9348-9363.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Raltegravir MethoxyEthylEster-Hydrazonic Using HRMS and NMR". J. Sep. Sci., 2024, 1928, (6), 8611-8623.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 拉替拉韦甲氧基乙酯-腙 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2018, 345, 7314-7324.